Delivery Order SPE2DB24D1021-SPE2DB25FESLB

Award Date 12/5/24
Potential Completion Date 12/6/24
Potential Value $62K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FESLB
    Delivery Order

This federal contract award, with an ID of SPE2DB24D1021|SPE2DB25FESLB, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $62,422.68 Firm Fixed Price contract is for the delivery of 4566626215 ENBREL 50 MG/ML SYRINGEML, a specialty pharmaceutical product.

The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

Generated 3/6/25, 10:00 AM